Elio
Category: AI in Climate / Energy
Elio is developing an AI-powered software platform to integrate sustainable design principles into pharmaceutical production, focusing on eco-friendly manufacturing processes. Elio was founded in 2021. The company is led by Kami Krista. Based in Vienna, Austria. Team size: N/A. Total funding raised: €1.9 million. Latest round: Pre-Seed funding led by Ananda Impact Ventures. Key investors include Ananda Impact Ventures, Stefan Oschmann (former CEO of Merck), Andreas Treichl (former CEO of Erste Group).
- Founded
- 2021
- Headquarters
- Vienna, Austria
- Team size
- N/A
- Total funding
- €1.9 million
Value proposition
Elio helps pharmaceutical companies make sustainable decisions early in the product development stage, optimizing environmentally friendly manufacturing processes.
Products and solutions
AI-powered eco-design software platform
Unique value
Elio's AI-driven approach to integrating sustainability into the design phase of pharmaceutical production sets it apart.
Target customer
Pharmaceutical companies and related industries.
Industries served
Pharmaceutical, Heavy manufacturing (future expansion)
Technology advantage
The use of AI to analyze and optimize the sustainability profile of reagents and other consumables in drug development.
How they differentiate
Elio's focus on integrating sustainability into the design phase using AI differentiates it from competitors who may focus on later stages of production.
Main competitors
Companies focusing on sustainable manufacturing and AI-driven solutions in the pharmaceutical sector
Key partnerships
ten23 health, Cytiva, My Green Lab
Notable customers
ten23 health
Major milestones
Securing €1.9 million in funding to advance sustainable pharmaceutical production solutions
Growth metrics
Not specified
Market positioning
Elio positions itself as a leader in sustainable pharmaceutical manufacturing, emphasizing eco-friendly practices without compromising innovation or quality.
Geographic focus
European market
Patents and IP
Not specified
About Kami Krista
Kami Krista is the Co-Founder and CEO of Elio, a company that is developing an AI-powered software platform to integrate sustainable design principles into pharmaceutical production. She is a bioengineer and a former pharmaceutical consultant. She has been recognized in Forbes 30 Under 30 for her work with Elio.
Official website: https://www.elio.earth